NTRK3-EML4-rearranged spindle cell tumor with co-expression of S100 and CD34: an unusual mesenchymal tumor in the spectrum of the bland-looking spindle cell lesions of the oral cavity

Giuseppe Broggi,Giulio Attanasio,Antonio Bonanno,Ignazio La Mantia,Sabina Barresi,Rita Alaggio,Gaetano Magro
DOI: https://doi.org/10.1016/j.oooo.2024.05.010
2024-05-29
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Abstract:A novel category of spindle cell tumors characterized by Neurotrophic Tyrosine Receptor Kinase (NTRK) rearrangements with a dual immunoreactivity for S-100 and CD34 has emerged in the last years as a distinct entity among soft tissue neoplasms. These genetic alterations lead to the continuous activation of NTRK genes, driving tumorigenesis and offering a unique prospect for targeted therapy. We herein present a rare case of NTRK3-rearranged spindle cell tumor with a hitherto unreported gene fusion involving the exon 14 of NTRK3 with the exon 2 of EML4, arising in the head & neck region.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?